A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2‐positive breast cancer

Noor Mazin Abdulkareem(University of Houston), Meghana V. Trivedi(University of Houston), Suhas Vasaikar(Baylor College of Medicine), Carmine De Angelis(Baylor College of Medicine), Rachel Schiff(Baylor College of Medicine), Hariprasad Thangavel(Hackensack Meridian Health), Ambily Gopinathan(University of Houston), Sarmistha Nanda(Baylor College of Medicine), Bing Zhang(Baylor College of Medicine), Lanfang Qin(Pancreatic Cancer Action Network), Martin J. Shea(Baylor College of Medicine), Tamika Mitchell(Baylor College of Medicine), Raksha R. Bhat(University of Houston)
The FASEB Journal
June 10, 2021
Cited by 25


Related Papers